MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with facilities in Irvine CA, Glasgow UK, and Singapore. They have been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease.

Medical Devices

MedAlliance Swiss Medical Technology

MedAlliance Swiss Medical Technology's headquarters in Irvine, CA, United States

The Nyon office focuses on manufacturing operations and clinical trial coordination in the biotechnology sector.

Nyon

The Ratingen office focuses on overseeing medical affairs and regulatory compliance in the pharmaceutical sector.

Ratingen

The Research and Development team at MedAlliance Swiss Medical Technology focuses on designing and enhancing innovative drug-eluting balloons (DEBs) to treat coronary and peripheral arterial diseases. This team conducts cutting-edge research, develops prototypes, and continually refines products to ensure efficacy and safety, contributing significantly to the company's mission of advancing patient care.

Research and Development

The Leadership Team at MedAlliance Swiss Medical Technology consists of key executives who strategically guide the company’s initiatives in developing innovative drug-eluting balloons. They collaborate to ensure operational excellence across various functions, including finance, quality, manufacturing, sales, and medical affairs, while driving growth in Asia and emerging markets. Their collective expertise shapes company direction, fosters innovation, and enhances patient outcomes in the medical technology sector.

Leadership Team

The Vice Presidents at MedAlliance Swiss Medical Technology are responsible for steering their respective departments to achieve the company's strategic objectives. Their roles include overseeing sales and marketing efforts, ensuring efficient manufacturing processes, managing financial activities, driving product development, maintaining high-quality standards, expanding into new markets, addressing medical affairs, optimizing operations, and advancing design engineering. Collectively, they play a crucial role in fostering innovation and ensuring the company's pioneering drug-eluting balloons reach patients in need.

Vice Presidents

The Clinical Affairs team at MedAlliance Swiss Medical Technology is responsible for designing, executing, and managing clinical trials related to drug-eluting balloons (DEBs) for coronary and peripheral arterial diseases. This team ensures all clinical research meets regulatory requirements, facilitates therapy development, and contributes to advancing medical treatments through rigorous scientific evaluation and collaboration.

Clinical Affairs

The Directors Team at MedAlliance Swiss Medical Technology is responsible for strategic planning and oversight across various divisions, ensuring the alignment of operational activities with the company’s goals. This team guides the innovation process in developing drug-eluting balloons (DEBs), oversees analytical chemistry, and manages manufacturing engineering and facilities to drive excellence and compliance in medical technology advancements.

Directors Team

The Finance Team at MedAlliance Swiss Medical Technology manages the company's financial health by overseeing budgeting, financial planning, and reporting. They ensure compliance with financial regulations, conduct audits, and provide strategic financial insights to support the company's development of innovative drug-eluting balloons for coronary and peripheral arterial disease.

��

People (1)

Jobs (0)

Other teams

Leadership Team

Vice Presidents

Clinical Affairs

Directors Team

Finance Team

��������

People (1)

Jobs (0)

Other teams

Leadership Team

Vice Presidents

Clinical Affairs

Directors Team

Finance Team

��